biospecifics.com Report : Visit Site

Technical data of the biospecifics.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host biospecifics.com. Currently, hosted in United States and its service provider is New Dream Network LLC .

lipomaboard.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

originators in the development of injectable collagenase home about biospecifics biospecifics overview leadership partnerships our technology collagen and scar tissue collagenase therapeutic use intellectual property pipeline pipeline dupuytren's contracture peyronie's disease adhesive capsulitis lipoma cellulite uterine fibroids additional indications investors stock information stock quote interactive chart ir snapshot historical stock price investment calculator analyst coverage financial reporting sec filings fundamentals ir key ratios annual reports corporate governance press releases events and presentation faqs email alerts get news alerts by email all rss feeds contact us contact contact us via email biospecifics has developed injectable collagenase for twelve clinical indications to date. find out more consistent profitability and strong intellectual property portfolio. find out more xiaflex® is currently marketed in the u.s. for dupuytren's contracture and peyronie's disease. find out more « 01 02 03 » pause frontpage slideshow | copyright © 2006-2012 joomlaworks ltd. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. injectable collagenase (collagenase clostridium histolyticum or cch) is marketed as xiaflex® in the u.s. for the treatment of dupuytren's contracture and peyronie's disease by biospecifics' partner, endo international plc (endo). xiaflex® is also commercialized in japan, europe, canada and australia for dupuytren’s contracture and for peyronie's disease in canada, europe and australia. endo is partnered with paladin labs, sobi, actelion and asahi kasei for dupuytren's contracture and/or peyronie's disease outside of the u.s. the xiaflex and cch research and development pipeline includes several additional promising indications. endo is opted-in to manage the development for cellulite, adhesive capsulitis, human and canine lipomas, lateral hip fat and plantar fibromatosis. endo initiated phase 3 clinical trials of cch for the treatment of cellulite in february 2018 with top-line results expected in the first quarter of 2019. biospecifics is managing the development of cch for the treatment of uterine fibroids. a phase 1 clinical trial is ongoing with top-line results expected in 2018. view the biospecifics 2018 corporate presentation recent news 9 may 2018 | 5:01 am reports first quarter 2018 financial results 14 mar 2018 | 5:01 am reports fourth quarter and full year 2017 financial results 12 mar 2018 | 1:30 pm announces presentation of interim data from phase 1 study of cch for the treatment of uterine fibroids at 65th annual scientific meeting of the society for reproductive investigation read more copyright © 2018 biospecifics technologies corp - all rights reserved. sitemap contact us search

URL analysis for biospecifics.com

http://www.biospecifics.com/home.html
http://www.biospecifics.com/component/fpss/track/15/l3bpcgvsaw5ll3bpcgvsaw5llmh0bww,.html
http://www.biospecifics.com/technology/collagen-and-scar-tissue.html
http://www.biospecifics.com/component/fpss/track/14/l3rly2hub2xvz3kvaw50zwxszwn0dwfslxbyb3blcnr5lmh0bww,.html
http://www.biospecifics.com/pipeline/pipeline.html
http://www.biospecifics.com/pipeline/adhesive-capsulitis.html
http://www.biospecifics.com/about-us/leadership.html
http://www.biospecifics.com/about-us/overview.html
http://www.biospecifics.com/sitemap.html
http://www.biospecifics.com/contact/contact-us-via-email.html?view=form
http://www.biospecifics.com/pipeline/peyronies.html
http://www.biospecifics.com/images/stories/pdfs/bstccorporatepresentationmay2018final.pdf
http://www.biospecifics.com/search.html
http://www.biospecifics.com/pipeline/cellulite.html
http://www.biospecifics.com/component/fpss/track/16/l3bpcgvsaw5ll2r1chv5dhjlbnmuahrtba,,.html

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: BIOSPECIFICS.COM
Registry Domain ID: 577817_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2017-12-11T22:20:45Z
Creation Date: 1996-11-13T05:00:00Z
Registry Expiry Date: 2022-11-12T05:00:00Z
Registrar: Network Solutions, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS39.WORLDNIC.COM
Name Server: NS40.WORLDNIC.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-07-28T16:00:07Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Network Solutions, LLC.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =biospecifics.com

  PORT 43

  TYPE domain

DOMAIN

  NAME biospecifics.com

  CHANGED 2017-12-11

  CREATED 1996-11-13

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS39.WORLDNIC.COM 207.204.40.120

  NS40.WORLDNIC.COM 207.204.21.120

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .